Cambridge Cognition Share Discussion Threads

[battlebus2] 07/3/2014 17:16

Good to see you here Cheshire Man i was feeling a little lonely :))
Not a big investment for me either but worthy of a little risk.

Yes looking forward to results but more important will be a clear signal that 2014 will see an improved performance.

[cheshire man] 07/3/2014 15:29

Joined you here today battlebus,,,,,dipping a small toe in for now, let's see what they have to say with this

Next annual report due 11/03/2014. (taken from TDW site)

[battlebus2] 06/3/2014 18:40

Still really under the radar this one with no trades today but i suspect we could be back to float price very soon.

[battlebus2] 05/3/2014 13:29

I've been buying these over the last while hoping to see a sharp return to 80p.
I reckon business has picked up and this should lead to a positive 2014 and a target price of £1 plus.
Lots of government focus in this field will only help imv but as ever dyor.

[ukinvestor220] 05/12/2013 15:31

Gosh this hasnt done very well has it !!

[outsizeclothes.com] 05/12/2013 14:46

Tanking. Somebody looking to exit in a hurry. New CEO's late Nov. statement re: revenue, orders and prospects only starting to sink in.

[hastings] 18/8/2013 21:53

hxxp://www.cambridge-news.co.uk/Business/Business-News/Boardroom-upset-at-listed-city-firm-20130814160250.htm

[bubbleandleek] 15/8/2013 07:47

Hearing they couldn't handle the pressure of being a plc. Too many meetings, questions being answered etc. I think the new guys coming in have an excellent track record. Will be ok in my view

[roger-lawson] 14/8/2013 20:05

Do an IPO and then in short order, change the chief executive and finance director. Weird to say the least. I hope there was a good reason for this because investors in the IPO might feel duped.

[lucky_punter] 24/4/2013 09:46

Cambridge Cognition Holdings (LON:COG)
Cambridge Cognition Holdings, which specialises in computerised neuropsychological tests including those enabling the early detection of dementia, announced its listing last week on AIM. On Admission, Cambridge Cognition raised approximately £5.0m (before expenses) and certain existing shareholders have realised a further £1.4m through the sale of existing ordinary shares.

[eswr] 19/4/2013 15:53

I would suggest you read the IPO prospectus and research document. This is NOT a pre revenue company but has a cash generative and profitable core business which provides the tests for academic research and for clinical trials research; the new area is GPs for Point of Care testing. Keep an eye out for the disclosure of shareholdings from new investors including a key name who is quite well respected in small cap investing.

[rocket fuel] 19/4/2013 12:13

another one for the mug punters to throw their cash at with no returns. expect mass dilution at every stage of the game. watch it head towards zero within the next 18 months!

[ukinvestor220] 19/4/2013 12:05

First Day of Dealings and Admission to Trading on AIM Placing to Raise £6.4m

Cambridge Cognition Holdings plc, (AIM: COG), which specialises in computerised neuropsychological tests including those enabling the early detection of dementia, announces the commencement, at 08.00 UK time this morning, of dealings in its Ordinary Shares on AIM, a market operated by the London Stock Exchange plc.
Highlights

On Admission, Cambridge Cognition has raised approximately £5.0m (before expenses) in the Placing of New Ordinary Shares and certain existing Shareholders have realised a further £1.4m through the Sale of existing Ordinary Shares
Placing Price for Placing Shares and Sale Shares was 70 pence per Ordinary Share
Market capitalisation of the Company following the Placing and at Admission is approximately £11.8m
Total number of Ordinary Shares in issue at Admission is 16,885,105
finnCap Limited acted as Nominated Adviser and Broker to the Company
Baker Botts (UK) LLP provided legal advice in respect to the Company's admission to AIM
Cambridge Cognition's trading symbol is COG and the Company's ISIN code is GB00B8DV9647

About Cambridge Cognition

Cambridge Cognition develops and commercialises computerised neuropsychological tests for sale worldwide, principally in the UK, the US and Europe.

Cambridge Cognition has created two well-established products, CANTABelect™ and CANTABeclipse™, which as standalone reportable segments have been profitable in each of the last three years. CANTABelect™ is for use in regulated clinical trials and CANTABeclipse™ is designed for use by researchers working in a non-regulated environment, typically in academia.

A third product, CANTABmobile™, was launched in the UK in May 2012, targeted at mainstream primary healthcare markets, in particular to enable the early detection of dementia.

The Directors intend to use funds raised in the Placing to grow sales of CANTABmobile™ and continue development of a similar product for secondary healthcare markets.

[praipus] 14/6/2011 23:11

Just recieved a dividend from this.....so long ago I'd forgotten I had any! When will we get the 12.84p per share I wonder?

[praipus] 28/3/2006 21:03

Better than the 7p stated in the earlier reconstruction proposal and with the DIVI ok.

Suspension of shares & issue prices under the Scheme

The City of Oxford Geared Income Trust plc

28 March 2006

Suspension of shares, calculation of TAVs and issue prices under the Scheme

The Board of The City of Oxford Geared Income Trust plc (the "Company") refers
to the circular (the "Circular") published by the Company on 28 February 2006
in relation to the recommended proposals for the reconstruction of the Company
(the "Scheme"). As set out in the Circular, and in accordance with the Scheme,
the listing of the Company's ZDP Shares, Income Shares and Geared Ordinary
Shares was suspended this morning.

The Company has calculated the terminal asset value ("TAV") of each of its
classes of shares under the Scheme as set out in that Circular and announces
that the TAV of a ZDP Share under the Scheme is 182.94p, the TAV of an Income
Share is 100p and the TAV of a Geared Ordinary Share is 12.84p.

The issue price of the new shares in Investec Capital Accumulator Trust Limited
and Glasgow Income Trust PLC to be issued under the Scheme has been calculated
and announced by those companies. The issue price of a new share in Investec
Capital Accumulator Trust Limited under the Scheme will be 103.5p and the issue
price of a new share in Glasgow Income Trust PLC will be 94.9p.

The Scheme and the issue of the new shares in Investec Capital Accumulator
Trust Limited and Glasgow Income Trust PLC under the Scheme are conditional
upon the admission of the new shares to the Official List of the UK Listing
Authority and to trading on the main market of the London Stock Exchange and to
the passing of the resolution to be proposed at the extraordinary general
meeting of the Company on 31 March 2006 to put the Company into liquidation.

All enquiries

Martin Slade
Company Secretary
Tel [phone]



END

[bingham] 28/3/2006 18:28

12.84p not too bad I suppose.

[praipus] 28/3/2006 16:53

Never realised agressive investing for capital growth was so relaxing....
zzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzz might do this instead of fishing in future.zzzzzzzzzzzzzzzzzzzz

[bingham] 28/3/2006 13:54

Next month it is then.
lol zzzzzzzzzzzzzzzzzzzzzzzzzzzzz

[praipus] 28/3/2006 13:37

Got the new battery now just teaching the Audit staff how to use it...

[praipus] 28/3/2006 11:23

zzzzzzzzzzzzzzz

[bingham] 28/3/2006 10:56

Martin must of nipp`d out to Wooley`s to buy a new battery for his calculator.
zzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzz

[praipus] 27/3/2006 16:55

Results of adjourned class meetings

The City of Oxford Geared Income Trust PLC (the "Company")

27 March 2006

Results of adjourned class meetings

The Company announces that the extraordinary resolutions, to consent to the
scheme of reconstruction of the Company, proposed at the separate general
meeting of holders of the ZDP Shares and the separate general meeting of
holders of the Geared Ordinary Shares, both convened for this morning, were
passed. The separate general meetings held this morning had been adjourned from
23 March 2006 and the extraordinary resolutions were set out in the notice of
those meetings.

Prints of the resolutions passed at the separate general meeting of the holders
of the ZDP Shares and at the separate general meeting of the holders of the
Geared Ordinary Shares held today have been forwarded to, and will shortly be
available for inspection at, the FSA's Document Viewing Facility, which is
situated at:

Financial Services Authority

25 The North Colonnade

Canary Wharf

London E14 5HS

Tel: [phone]

Enquiries

Martin Slade
Company Secretary
Tel [phone]





END

Bit frustrating so far this game

[praipus] 27/3/2006 11:45

Trustnet says NAV 15.81p 30.5% discount (14.27p according to splitsonline 22.9% discount) buying now would give you a theoretical 22-30% discount on rolling in to GIT (GLS)less windup costs and charges...arbitrage opportunity?